LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $462,000 | -40.2% | 320,509 | -17.2% | 0.04% | -39.7% |
| Q2 2020 | $772,000 | +11.7% | 387,035 | +9.2% | 0.07% | -11.0% |
| Q1 2020 | $691,000 | -54.7% | 354,285 | -3.6% | 0.08% | -39.7% |
| Q4 2019 | $1,526,000 | +27.2% | 367,662 | -7.8% | 0.14% | +16.2% |
| Q3 2019 | $1,200,000 | -1.8% | 398,684 | +105.1% | 0.12% | -4.9% |
| Q2 2019 | $1,222,000 | +50.3% | 194,339 | +33.0% | 0.12% | +41.4% |
| Q1 2019 | $813,000 | -29.8% | 146,157 | -16.2% | 0.09% | -41.2% |
| Q4 2018 | $1,158,000 | -13.3% | 174,442 | +39.4% | 0.15% | -2.0% |
| Q3 2018 | $1,335,000 | -26.5% | 125,130 | -17.3% | 0.15% | -32.9% |
| Q2 2018 | $1,816,000 | +36.3% | 151,350 | -2.6% | 0.22% | +29.3% |
| Q1 2018 | $1,332,000 | -3.1% | 155,396 | +11.7% | 0.17% | +3.6% |
| Q4 2017 | $1,374,000 | -0.4% | 139,106 | +23.9% | 0.17% | -6.1% |
| Q3 2017 | $1,379,000 | -4.4% | 112,233 | +28.1% | 0.18% | -4.3% |
| Q2 2017 | $1,442,000 | +89.5% | 87,640 | +65.2% | 0.19% | +81.6% |
| Q1 2017 | $761,000 | +176.7% | 53,054 | +166.4% | 0.10% | +157.5% |
| Q4 2016 | $275,000 | – | 19,914 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |